<DOC>
	<DOCNO>NCT01525810</DOCNO>
	<brief_summary>The primary purpose study determine whether hepatitis C virus continue remain unable detected subject previously treat BMS-914143 achieve sustained virologic response</brief_summary>
	<brief_title>Three-year Follow-up Study Subjects Who Participated Previous Lambda ( BMS-914143 ) Chronic Hepatitis C Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Subjects must receive Lambda previous trial Hepatitis C virus ( HCV ) Ribonucleic acid ( RNA ) &lt; LOQ completion require posttreatment followup ( must enter study within 6 month completion require posttreatment followup previous trial ) NOTE : For blind parent trial , subject HCV RNA &lt; LOQ completion require posttreatment followup may enter study without knowledge treatment assignment parent study . Subjects receive control agent ( eg , pegylatedinterferon alfa ) previous protocol allow participate unblinded treatment information release ; time subject option continue study Subjects must treat antiviral immunomodulatory drug chronic hepatitis C completion previous study Lambda</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>